Seife v. FDA (S.D.N.Y.) -- ruling that with the exception of a few documents, FDA properly relied on Exemption 5’s deliberative process privilege to withhold records pertaining to news embargoes between 2010 and 2014; stating that statute’s “foreseeable harm” provision did not apply to requests made before 2016, but that in any event FDA “met any applicable burden.”
Summaries of all published opinions issued since April 2015 are available here.